These data suggest mechanical stimulation of TGFβ signalling could be essential in promoting, further, the DCIS myoepithelial phenotype associated with progression to invasion, and that these markers may be used to identify patients at higher risk for invasive progression. The gene discussed is TGFB1; the disease is ductal breast carcinoma in situ.